Pyrazole compounds that are potent and selective inhibitors of PDE4, as
well as methods of making the same, are disclosed. Use of the compounds
in the treatment of inflammatory diseases and other diseases involving
elevated levels of cytokines, as well as central nervous system (CNS)
disorders, also is disclosed.